For pregnant women who are positive for hepatitis B virus surface antigen, the main treatment plan is to do blocking treatment in the late pregnancy to prevent vertical transmission from mother to child.
Found that pregnant women with hepatitis B virus surface antigen positive may be infected for a short period of time or chronic hepatitis B carrier status, the entire pregnancy should pay attention to close monitoring of hepatitis B 5 and liver function, to determine the physical condition of the pregnant woman herself. In late pregnancy, one injection of immunoglobulin should be given in the 7th, 8th and 9th month of pregnancy, and the newborn should be injected with hepatitis B immunoglobulin and hepatitis B vaccine immediately after delivery.
Most of the infections can be prevented by blocking the treatment. After birth, closely monitor the liver function of the child and the 5 items of hepatitis B, and consult the doctor in time when any abnormality is found, so as not to affect the health of the child.